Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report

被引:2
作者
Arrighi, Lucas [1 ]
Maakaron, Eloise [1 ]
Korchia, Theo [1 ]
Lancon, Christophe [1 ]
Richieri, Raphaelle [1 ,2 ]
机构
[1] St Marguerite Univ Hosp, Publ Assistance Marseille Hosp, Dept Psychiat, Marseille, France
[2] Aix Marseille Univ, Ecole Cent Marseille, Fresnel Inst, Imothep Team,CNRS,UMR 7249, Marseille, France
关键词
case report; esketamine; intranasal; treatment-resistant depression; ORAL ANTIDEPRESSANT; SAFETY; EFFICACY;
D O I
10.1097/YIC.0000000000000482
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
About 30% of patients with major depressive disorder have treatment-resistant depression (TRD). Recently, intranasal esketamine was approved as a treatment option after the failure of two antidepressant trials. We report a patient with multiresistant depression that was successfully and safely treated with esketamine nasal spray. This 31-year-old inpatient with severe, chronic, and multi-TRD received an acute course of intranasal esketamine (84 mg). Previously, 14 different antidepressants, alone or in potentiation, and several neurostimulation techniques had been unsuccessful. Over 20 bi-weekly sessions, she had no significant adverse effects and was stabilized into remission. During the maintenance phase and 1 year after, she continues to be stable. This case report provides an example of a patient with severe TRD that showed significant improvement after treatment with intranasal esketamine.
引用
收藏
页码:323 / 325
页数:3
相关论文
共 10 条
[1]   Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study [J].
Brendle, Madeline ;
Ahuja, Sachin ;
Della Valle, Maisa ;
Moore, Claire ;
Thielking, Paul ;
Malone, Daniel C. ;
Robison, Reid .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (18) :1323-1336
[2]   Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review [J].
Capuzzi, Enrico ;
Caldiroli, Alice ;
Capellazzi, Martina ;
Tagliabue, Ilaria ;
Marcatili, Matteo ;
Colmegna, Fabrizia ;
Clerici, Massimo ;
Buoli, Massimiliano ;
Dakanalis, Antonios .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
[3]   Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial [J].
Daly, Ella J. ;
Singh, Jaskaran B. ;
Fedgchin, Maggie ;
Cooper, Kimberly ;
Lim, Pilar ;
Shelton, Richard C. ;
Thase, Michael E. ;
Winokur, Andrew ;
Van Nueten, Luc ;
Manji, Husseini ;
Drevets, Wayne C. .
JAMA PSYCHIATRY, 2018, 75 (02) :139-148
[4]  
Dunner D.L., 2020, Neurol Psychiat Br Research, V36, P30, DOI [10.1016/j.npbr.2020.02.008, DOI 10.1016/J.NPBR.2020.02.008]
[5]   The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review [J].
Levinta, Anastasia ;
Meshkat, Shakila ;
McIntyre, Roger S. ;
Ho, Cameron ;
Lui, Leanna M. W. ;
Lee, Yena ;
Mansur, Rodrigo B. ;
Teopiz, Kayla M. ;
Rodrigues, Nelson B. ;
Di Vincenzo, Joshua D. ;
Ceban, Felicia ;
Rosenblat, Joshua D. .
JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 :139-149
[6]   Real-World experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) [J].
Martinotti, Giovanni ;
Vita, Antonio ;
Fagiolini, Andrea ;
Maina, Giuseppe ;
Bertolino, Alessandro ;
Dell'Osso, Bernardo ;
Siracusano, Alberto ;
Clerici, Massimo ;
Bellomo, Antonello ;
Sani, Gabriele ;
d'Andrea, Giacomo ;
Delle Chiaie, Roberto ;
Conca, Andreas ;
Barlati, Stefano ;
Di Lorenzo, Giorgio ;
De Fazio, Pasquale ;
De Filippis, Sergio ;
Nicolo, Giuseppe ;
Rosso, Gianluca ;
Valchera, Alessandro ;
Nucifora, Domenica ;
Di Mauro, Stefania ;
Bassetti, Roberta ;
Martiadis, W. Vassilis ;
Olivola, Miriam ;
Belletti, Sandro ;
Andriola, Ileana ;
Di Nicola, Marco ;
Pettorruso, Mauro ;
McIntyre, Roger S. ;
di Giannantonio, Massimo ;
REAL ESK Study Grp .
JOURNAL OF AFFECTIVE DISORDERS, 2022, 319 :646-654
[7]   Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study [J].
Popova, Vanina ;
Daly, Ella J. ;
Trivedi, Madhukar ;
Cooper, Kimberly ;
Lane, Rosanne ;
Lim, Pilar ;
Mazzucco, Christine ;
Hough, David ;
Thase, Michael E. ;
Shelton, Richard C. ;
Molero, Patricio ;
Vieta, Eduard ;
Bajbouj, Malek ;
Manji, Husseini ;
Drevets, Wayne C. ;
Singh, Jaskaran B. .
AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06) :428-438
[8]   Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report [J].
Rush, A. John ;
Trivedi, Madhukar H. ;
Wisniewski, Stephen R. ;
Nierenberg, Andrew A. ;
Stewart, Jonathan W. ;
Warden, Diane ;
Niederehe, George ;
Thase, Michael E. ;
Lavori, Philip W. ;
Lebowitz, Barry D. ;
McGrath, Patrick J. ;
Rosenbaum, Jerrold F. ;
Sackeim, Harold A. ;
Kupfer, David J. ;
Luther, James ;
Fava, Maurizio .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (11) :1905-1917
[9]   Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme [J].
Samalin, Ludovic ;
Rotharmel, Maud ;
Mekaoui, Lila ;
Gaudre-Wattinne, Emeline ;
Codet, Marie-Alix ;
Bouju, Sophie ;
Sauvaget, Anne .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2022, 26 (04) :352-362
[10]   Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States [J].
Swapna, K. Arkar E. ;
Zhdanava, Maryia ;
Pilon, Dominic ;
Nash, Abigail I. ;
Morrison, Laura ;
Shah, Aditi ;
Patrick, Lef Ebvr E. ;
Joshi, Kruti .
CLINICAL THERAPEUTICS, 2022, 44 (11) :1432-1448